Journals / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 4

In vitro gene silencing effect of chitosan/shRNA PDGF-D nanoparticles in breast cancer

Pages
793–803
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was also evaluated that chitosan can be a suitable gene delivery system for shRNA targeting PDGF-D.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast cancer is the most common cancer worldwide in women and it is highly malignant and fatal.
📊
Key Findings & Data:Silencing of PDGF-D gene by using shRNA with an appropriate carrier system may decrease tumor growth and metastasis.
💡
Conclusion & Impact:It was also evaluated that chitosan can be a suitable gene delivery system for shRNA targeting PDGF-D.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Breast cancer is the most common cancer worldwide in women and it is highly malignant and fatal. PDGF-D plays role in regulation of many cellular processes such as angiogenesis. PDGF-D is overexpressed in many types of cancers and promote tumor growth and metastasis. Silencing of PDGF-D gene by using shRNA with an appropriate carrier system may decrease tumor growth and metastasis. In our study, we prepared chitosan nanoparticles loaded with five different shRNA plasmids targeting different exons of PDGF-D gene. Then, nanoparticles were characterized in vitro and transfection efficiency of these nanoparticles were investigated in breast cancer cell lines (MCF7, MDA-MB-231 and MDA-MB-435). The effects of single and multiple shRNA sequences, molecular weight of chitosan (150 kDa and 400 kDa) and the amount of shRNA (100 and 500 µg) on the characterization and transfection efficiencies of nanoparticles have been studied. Size of nanoparticles changed between 200-400 nm and approximately 95-100% encapsulation efficiency were obtained. Release of shRNA changed with the molecular weight of chitosan. It was obtained that formulation containing shRNA plasmid targeting PDGF-D exon 6 (NP1) has the highest silencing efficiency in MDA-MB-231 cell line. It was also evaluated that chitosan can be a suitable gene delivery system for shRNA targeting PDGF-D.

🔖

Cite This Article

EKENTOK, C., TURAN, S. Ö., AKBUĞA, J. (2017). In vitro gene silencing effect of chitosan/shRNA PDGF-D nanoparticles in breast cancer. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 4, 793–803. https://ajindex.com/articles/283699

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Zhang L, Yang L, Mohamed-Hadley A, Rubin S.C, Coukosa G. Vector-based RNAi, a novel tool for isoform-specific knockdown of VEGF and anti-angiogenesis gene therapy of cancer. Biochem Biophys Res Commun 2003; 303: 1169-78.
  2. Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 1997; 63: 125-32.
  3. Ando S, Putnam D, Pack DW, Langer R. PLGA microspheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. J Pharm Sci 1999; 88: 126-30.
  4. Sambrook J, Fritsch EF, Maniatis T (eds). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: USA, 1989.
  5. Xu L, Tong R, Cochran DM, Jain RK. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotropic mouse model. Cancer Res 2005; 65: 5711-9.
  6. Salva E, Kabasakal L, Eren F, Çakalağaoğlu F, Özkan N, Akbuğa J. Chitosan/short hairpain RNA complexes for vascular endothelial growth factor suppression invasive breast carcinoma. Oligonucleotides 2010; 20: 183-90.
  7. Salva E, Akbuğa J. In vitro silencing effect of chitosan nanoplexes containing siRNA expressing vector targeting VEGF in breast cancer cell lines. Pharmazie 2010; 65: 896-903.
  8. Ozbaş-Turan S, Akbuğa J, Sezer AD. Topical application of antisense oligonucleotide-loaded chitosan nanoparticles to rats. Oligonucleotides 2010; 20: 147-53.
  9. Salva E, Akbuga J. Comparison of silencing effect of chitosan/ psiRNA complexes in different cell lines. Adv Chitin Sci 2009; 11: 203-8.
  10. Ozbas-Turan S, Akbuğa J, Enneli B. Evaluation of antisense oligonucleotide loaded chitosan nanoparticles; characterization and antisense effect. Pharmazie 2009; 64: 807-11.
  11. Akbuğa J, Aral C, Özbaş-Turan S, Kabasakal L, Keyer-Uysal M. Transfection efficiency of chitosan microspheres effect of DNA topology. STP Pharm Sci 2003; 13: 99–103.
  12. Mao H-Q, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001; 70: 399-421.
  13. Filion MC, Phillips NC. Major limitations in the use of cationic liposomes for gene delivery. Int J Pharm 1998; 162: 159-70.
  14. Scales CW, Huang F, Li N, Vasilieva YA, Ray J, Convertine AJ, McCormick MC. Corona-stabilized interpolyelectrolyte complexes of siRNA with non-immunogenic, hydrophilic/ cationic blo